Speciality Medicines GMP IPO Date, Review, Price, Allotment Details
Speciality Medicines IPO Summary
IPO Open Date: 20 Mar 2026
IPO Close Date: 24 Mar 2026
Price Band: ₹117 to ₹124 Per Share
Issue Size: Approx ₹29.14 Crores
Listing Exchange: BSE SME
Website: https://www.specialitymedicine.com/
Speciality Medicines IPO Overview
Speciality Medicines IPO is a book build issue of ₹29.14 crores. The issue is entirely a fresh issue of 0.24 crore shares of ₹29.14 crore.
Speciality Medicines IPO opens for subscription on Mar 20, 2026 and closes on Mar 24, 2026. The allotment for the Speciality Medicines IPO is expected to be finalized on Mar 25, 2026. Speciality Medicines IPO will list on BSE SME with a The tentative listing date fixed as Mar 30, 2026.
Speciality Medicines IPO is set issue price band at ₹117 to ₹124 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹0.00 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹3,72,000.
Speciality Medicines IPO Details
| Company Name | Speciality Medicines Ltd. |
| IPO Open Date | 20 Mar 2026 |
| IPO Close Date | 24 Mar 2026 |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹117 to ₹124 Per Share |
| Issue Size | Approx ₹29.14 Crores |
| Fresh Issue | Approx ₹29.14 Crores |
| Offer for Sale | - |
| Issue Type | Book build Issue |
| Listing On | BSE SME |
Speciality Medicines IPO Market Lot
The Speciality Medicines IPO minimum market lot is 2,000 shares with ₹2,48,000 application amount.
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | ₹2,48,000 |
| Retail Maximum | 2 | 2,000 | ₹2,48,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,72,000 |
| S-HNI Maximum | 8 | 8,000 | ₹9,92,000 |
| B-HNI Minimum | 9 | 9,000 | ₹11,16,000 |
Speciality Medicines IPO Reservation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 2% |
| NII / HNI | – Shares | 49% |
| Retail | – Shares | 49% |
Speciality Medicines IPO Dates & Allotment
The Speciality Medicines IPO date is March 20 and the close date is March 24. The Speciality Medicines IPO allotment will be finalized on March 25 and the IPO listing on March 30.
| IPO Opening Date | 20 Mar 2026 |
| IPO Closing Date | 24 Mar 2026 |
| Bidding Cutoff Time | 5 PM |
| Basis of Allotment | 25 Mar 2026 |
| Refunds Initiation | 27 Mar 2026 |
| Credit to Demat | 27 Mar 2026 |
| IPO Listing Date | 30 Mar 2026 |
Speciality Medicines IPO Objects of the Issue & Utilization of Proceeds
| Description | Amount |
|---|---|
| Setting up of the Research and Development (R&D) Centre | ₹13.31 |
| Product registration in the international markets | ₹2.89 |
| Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company | ₹1.75 |
| To Meet Working Capital Requirements | ₹12.00 |
| General Corporate Purpose | ₹- |
Speciality Medicines Ltd. Financials
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | ₹27.66 | ₹23.10 | ₹2.93 | ₹22.68 |
| 2025 | ₹58.54 | ₹49.85 | ₹8.61 | ₹39.98 |
| Oct 2025 | ₹36.93 | ₹30.80 | ₹6.06 | ₹45.57 |
Speciality Medicines IPO Valuation
Check Speciality Medicines IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Parameter | Value |
|---|---|
| Earnings Per Share (EPS) | ₹14.10 (Basic) |
| P/E Ratio | N/A |
| Return on Equity (ROE) | 37.85% |
| Return on Capital Employed (ROCE) | 33.39% |
| Return on Net Worth (RoNW) | 28.42% |
| Net Asset Value (NAV) | ₹47.07 |
| EBITDA Margin | 15.60% |
| PAT Margin | 14.77% |
| Debt to Equity Ratio | 0.17 |
Speciality Medicines IPO Peer Group Comparison
| Company | EPS | P/E | RoNW % | NAV | Total Income |
|---|---|---|---|---|---|
| Remus Pharmaceuticals Limited | 65.21 | 12.25 | 15.02% | 434.25 | 620.36 Cr. |
| Trident Lifeline Limited | 10.22 | 27.59 | 18.23% | 56.05 | 86.96 Cr. |
| Mono Pharmacare Limited | 1.75 | 13.87 | 9.90% | 17.66 | 168.34 Cr. |
Speciality Medicines IPO Promoters & Holding Pattern
The promoters of the company are Parth B Goyani and Goyani Sumit Babubhai.
| Particulars | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 64,35,796 | 59.28% |
| Promoter Holding Post Issue | 87,85,796 | -% |
Speciality Medicines IPO Lead Managers (Merchant Bankers)
- Unicon Capital Services Pvt. Ltd.
About Speciality Medicines Ltd.
Speciality Medicines is a premier pharmaceutical organization dedicated to the distribution and formulation of high-value, critical care medications across international markets. The company addresses complex therapeutic requirements through a robust supply chain and strategic alliances with global healthcare providers. By maintaining rigorous quality standards and regulatory compliance, they facilitate seamless access to life-saving treatments for rare and chronic health conditions.
Speciality Medicines Ltd. Address
Ahmedabad, Gujarat, 380051Phone: +91 22 4604 5344
Email: [email protected]
Speciality Medicines IPO Registrar
Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: [email protected]
Website: https://www.skylinerta.com/ipo.php